Attached files
file | filename |
---|---|
10-Q/A - NUTRA PHARMA CORP | v171819_10qa.htm |
EX-31.1 - NUTRA PHARMA CORP | v171819_ex31-1.htm |
EXHIBIT
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report of Nutra Pharma Corp., (the "Company") on
Form 10-Q, Amendment No. 1, for the quarterly period ended September
30, 2009, as filed with the Securities and Exchange Commission on the date
hereof (the "Report"), I, Rik Deitsch, the Chief Executive Officer and Chief
Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:
1.
|
The Report fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act
of 1934; and
|
|
2.
|
The information contained in the
Report fairly presents, in all material respects, the financial condition
and results of operations of the
Company.
|
Dated:
January 25, 2010
|
/s/ Rik J. Deitsch
|
Rik
J. Deitsch
|
Chief
Executive Officer and Chief Financial
Officer
|